Gilead Sciences
GILD
#103
Rank
NZ$327.04 B
Marketcap
NZ$263.76
Share price
2.17%
Change (1 day)
38.42%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): NZ$18.33 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.73 Billion. In 2025 the company made an earning of NZ$17.12 Billion, an increase over its 2024 earnings that were of NZ$1.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$18.33 B7.09%
2025 NZ$17.12 B1319.86%
2024 NZ$1.20 B-89.94%
2023 NZ$11.98 B17.97%
2022 NZ$10.16 B-29.77%
2021 NZ$14.46 B395.99%
2020 NZ$2.91 B-67.66%
2019 NZ$9.01 B-33.84%
2018 NZ$13.63 B-42.35%
2017 NZ$23.64 B-20.87%
2016 NZ$29.88 B-21.06%
2015 NZ$37.85 B45.8%
2014 NZ$25.96 B253.01%
2013 NZ$7.35 B16.51%
2012 NZ$6.31 B-1.07%
2011 NZ$6.38 B-6.71%
2010 NZ$6.84 B11.75%
2009 NZ$6.12 B29.5%
2008 NZ$4.72 B19.11%
2007 NZ$3.96 B-455.74%
2006 -NZ$1.12 Billion-154.93%
2005 NZ$2.03 B76.99%
2004 NZ$1.14 B-266.16%
2003 -NZ$0.7 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$97.56 M-242.15%
2000 -NZ$68.64 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$87.06 Million8.73%
1997 -NZ$80.06 Million27.22%
1996 -NZ$62.93 Million
1994 -NZ$59.96 Million26.57%
1993 -NZ$47.38 Million46.49%
1992 -NZ$32.34 Million362.5%
1991 -NZ$7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.41 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.51 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.44 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.40 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.88 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.83 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.02 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.84 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.98 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA